As of 2025-07-04, the Relative Valuation of Laboratorios Farmaceuticos ROVI SA (ROVI.MC) is 51.88 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 55.65 EUR, the upside of Laboratorios Farmaceuticos ROVI SA based on Relative Valuation is -6.8%.
The range of the Relative Valuation is 44.00 - 71.49 EUR.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 26.2x | 19.4x |
| Forward P/E multiples | 16.0x - 23.8x | 18.5x |
| Fair Price | 44.00 - 71.49 | 51.88 |
| Upside | -20.9% - 28.5% | -6.8% |
| Date | P/E |
| 2025-07-02 | 20.40 |
| 2025-07-01 | 20.24 |
| 2025-06-30 | 20.04 |
| 2025-06-27 | 20.09 |
| 2025-06-26 | 19.85 |
| 2025-06-25 | 19.58 |
| 2025-06-24 | 19.76 |
| 2025-06-23 | 19.76 |
| 2025-06-20 | 20.15 |
| 2025-06-19 | 20.16 |
| 2025-06-18 | 20.15 |
| 2025-06-17 | 20.31 |
| 2025-06-16 | 20.55 |
| 2025-06-13 | 20.49 |
| 2025-06-12 | 20.84 |
| 2025-06-11 | 20.68 |
| 2025-06-10 | 20.53 |
| 2025-06-09 | 20.44 |
| 2025-06-05 | 20.16 |
| 2025-06-04 | 20.31 |
| 2025-06-03 | 19.72 |
| 2025-06-02 | 19.72 |
| 2025-05-30 | 19.93 |
| 2025-05-29 | 19.30 |
| 2025-05-28 | 19.29 |
| 2025-05-27 | 19.16 |
| 2025-05-26 | 19.08 |
| 2025-05-23 | 18.88 |
| 2025-05-22 | 18.96 |
| 2025-05-21 | 19.32 |
| 2025-05-20 | 19.30 |
| 2025-05-19 | 19.01 |
| 2025-05-16 | 19.30 |
| 2025-05-15 | 19.18 |
| 2025-05-14 | 19.32 |
| 2025-05-13 | 19.56 |
| 2025-05-12 | 19.76 |
| 2025-05-09 | 19.30 |
| 2025-05-08 | 19.29 |
| 2025-05-07 | 18.79 |
| 2025-05-06 | 19.05 |
| 2025-05-05 | 19.16 |
| 2025-05-02 | 19.05 |
| 2025-04-30 | 18.86 |
| 2025-04-29 | 18.81 |
| 2025-04-28 | 18.74 |
| 2025-04-25 | 18.72 |
| 2025-04-24 | 18.70 |
| 2025-04-23 | 18.54 |
| 2025-04-22 | 18.15 |